FDA Approves First Drug to Treat Severe Multiple Sclerosis – New York Times
New York Times |
FDA Approves First Drug to Treat Severe Multiple Sclerosis
New York Times Jerrie Gullick, 51, was part of the clinical trial for Ocrevus and said the drug had significantly slowed the progression of her primary progressive multiple sclerosis. Credit Sam Hodgson for The New York Times. The Food and Drug Administration … New MS Drug Ocrevus Wins FDA Approval FDA approves first treatment for severe type of multiple sclerosis USF played a key role in approval of new MS drug |
Powered by WPeMatico